Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002715 · ClinicalTrials.gov registry record · Phase 2
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00002715: Completed Phase 2 study, sponsored by Stanford University.
NCT00002715 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 50 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002715, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have advanced Hodgkin's lymphoma.
Interventions
- DRUG Etoposide
- DRUG Doxorubicin hydrochloride
- DRUG Stanford V regimen
- BIOLOGICAL Bleomycin sulfate
- DRUG Mechlorethamine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1989-04 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
What the finished NCT00002715 record still lists
NCT00002715 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (62% lower).
The record links to 0 conditions, and to 5 interventions - of which Etoposide is the first listed.
NCT00002715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002715 about?
NCT00002715 is a clinical study titled "Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have advanced Hodgk...
What is the current status of trial NCT00002715?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 1989-04. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00002715?
The interventions under investigation include: Etoposide (DRUG), Doxorubicin hydrochloride (DRUG), Stanford V regimen (DRUG), Bleomycin sulfate (BIOLOGICAL), Mechlorethamine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002715?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002715's enrollment target sits among peer trials
50 1195th of 2000 higher than 740 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia